Product Information

TESTOSTERONE 1.62%(1.25 G) PKT is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $3.9336 per GM under NDC 45802028139. Its NADAC has been published 363 times since Dec 11, 2019.

FDA first approved this application on Jul 12, 2017. Its Orange Book therapeutic-equivalence code is AB2 — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

TESTOSTERONE 1.62%(1.25 G) PKT

testosterone
$3.9336per GM
DEA Schedule CIII

Strength

20.25 mg/1.25g

NDC

45802028139

Classification

Generic

Dosage Form

GEL

Route

TOPICAL

Effective Date

11/18/2026

Active Ingredients

TESTOSTERONE

Approval Type

Generic (ANDA)

FDA Application

ANDA205781

FDA Approved

7/12/2017

TE Code

AB2

On Market Since

6/27/2019

Pharmacological Classes

Androgen Receptor Agonists
Androgen
Androstanes

Price Statistics

The NADAC for TESTOSTERONE 1.62%(1.25 G) PKT has been published 363 times since Dec 11, 2019, and over the history we have for it it has declined 39.7%. The table below summarizes its recorded NADAC range and movement.

Current price$3.9336 per GM
All-time high$8.9591 (Jan 13, 2021)
All-time low$2.4476 (Apr 17, 2024)
52-week high$4.0792
52-week low$2.8842
Median price$4.5561
Average price$4.8834
Largest weekly change+62.3% (Aug 21, 2024)
Weeks tracked363
Tracking sinceDec 11, 2019

Price History

1W

-3.6%

1M

+7.8%

3M

+20.8%

6M

+11.8%

1Y

+14.3%

3Y

+14.9%

5Y

-9.4%

All

-39.7%

Generic Alternatives

The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Lowest-Cost Alternatives

1 alternative • Same active ingredient

Continue researching this drug

Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.

Frequently asked questions

What is the NADAC price of TESTOSTERONE 1.62%(1.25 G) PKT?

The current National Average Drug Acquisition Cost (NADAC) for TESTOSTERONE 1.62%(1.25 G) PKT, manufactured by Padagis Israel Pharmaceuticals Ltd, is $3.9336 per GM (NDC 45802028139), effective Nov 18, 2026.

How has the price of TESTOSTERONE 1.62%(1.25 G) PKT changed over time?

Over the history we have for it, the NADAC for TESTOSTERONE 1.62%(1.25 G) PKT has declined 39.7%. It has been tracked across 363 weekly CMS publications since Dec 11, 2019.

What are the highest and lowest recorded NADAC prices for TESTOSTERONE 1.62%(1.25 G) PKT?

Since Dec 11, 2019, the NADAC for TESTOSTERONE 1.62%(1.25 G) PKT has ranged from a low of $2.4476 (Apr 17, 2024) to a high of $8.9591 (Jan 13, 2021), with a median of $4.5561 per GM.

Are there cheaper alternatives to TESTOSTERONE 1.62%(1.25 G) PKT?

1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as TESTOSTERONE 1.62%(1.25 G) PKT in a comparable dosage form, but none are currently priced below it.

Who manufactures TESTOSTERONE 1.62%(1.25 G) PKT?

TESTOSTERONE 1.62%(1.25 G) PKT (NDC 45802028139) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.